BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Esposito P, Domenech MV, Serpieri N, Calatroni M, Massa I, Avella A, La Porta E, Estienne L, Caramella E, Rampino T. Severe cyclophosphamide-related hyponatremia in a patient with acute glomerulonephritis. World J Nephrol 2017; 6(4): 217-220 [PMID: 28729970 DOI: 10.5527/wjn.v6.i4.217]
URL: https://www.wjgnet.com/2220-6124/full/v6/i4/217.htm
Number Citing Articles
1
Ola A. Abdelwahab Mostafa, Fatma Ibrahim, Eman Borai. Protective effects of hesperidin in cyclophosphamide-induced parotid toxicity in ratsScientific Reports 2023; 13(1) doi: 10.1038/s41598-022-26881-w
2
Claudio Ponticelli, Richard J. Glassock. Prevention of complications from use of conventional immunosuppressants: a critical reviewJournal of Nephrology 2019; 32(6): 851 doi: 10.1007/s40620-019-00602-5
3
Jiali Chen, Yuebo Jin, Chun Li, Zhanguo Li. Symptomatic hyponatremia induced by low-dose cyclophosphamide in patient with systemic lupus erythematosusMedicine 2020; 99(48): e22498 doi: 10.1097/MD.0000000000022498
4
Ming Tian, Xiaohong Song, Liping Dong, Xing Xin, Junwu Dong. Systematic evaluation of different doses of cyclophosphamide induction therapy for lupus nephritisMedicine 2017; 96(51): e9408 doi: 10.1097/MD.0000000000009408
5
M. Delin, J.-M. Gilardoni, M. Cremoni, M. Ben Hayoun, G. Keirle, J. Pradelli, J. Benzaquen, S. Leroy. Rôle de l’hyponatrémie dans la survenue rapide d’un coma après CyclophosphamideRevue des Maladies Respiratoires 2022; 39(6): 571 doi: 10.1016/j.rmr.2022.04.007
6
Pasquale Esposito, Daniela Picciotto, Francesca Cappadona, Francesca Costigliolo, Elisa Russo, Lucia Macciò, Francesca Viazzi. Multifaceted relationship between diabetes and kidney diseases: Beyond diabetesWorld Journal of Diabetes 2023; 14(10): 1450-1462 doi: 10.4239/wjd.v14.i10.1450